Lee’s Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights

2025-12-10 – Press Releases – www.prnewswire.com

Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potential Synergistic and complementary to Lee’s Pharm’s existing products pipeline, and Acquisition of rights as licensor and manufacturer of Staccato® alprazolam under a global…

Read the full article here.